enGene Therapeutics ENGN
NASDAQ ENGN
$2.41 +0.13 (+5.70%)
At close: Nov 13, 2026 · 4:00 PM EST

enGene Therapeutics (ENGN) Net Shares Issued and Repurchased (2023 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Net Shares Issued and Repurchased (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -966.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -5.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -283.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 enGene Therapeutics 161.50 Mn -832.97 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 23,000.00
Apr 30, 2026 4,000.00
Jan 31, 2026 149.78 Mn
Oct 31, 2025 1.99 Mn
Jul 31, 2025 32,000.00
Apr 30, 2025 199,000.00
Jan 31, 2025 1,000.00
Oct 31, 2024 60.16 Mn
Jul 31, 2024 51,000.00
Oct 31, 2023 56.92 Mn
API Access

enGene Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=ENGN&period=max&api_key=YOUR_API_KEY